The Protective Effect of Bosentan against Atherosclerosis in Apolipoprotein E-Deficient Mice Is Mediated by miRNA-21

Table 1

The body weights of mice in the control, ApoE^−/−, and bosentan groups at baseline and after 12 weeks of treatment.

Group	Number of animals	Body weight (g)	Body weight (g)
		At week 6	At week 12
Control	10	15.98 ± 0.19	28.20 ± 0.82
ApoE^–/–	10	15.95 ± 0.29	33.62 ± 0.57
ApoE^–/– + bosentan	10	15.99 ± 0.20	32.04 ± 0.72

vs. control group; vs. ApoE^−/−, group; n = 10/group.